Patent application number | Description | Published |
20090241263 | MEDICAL EXAMINATION TABLE - A medical examination table is provided. The medical examination table comprises a base providing a storage area, a patient support movable independent of the base between a lowered position and a raised position, and a lift mechanism coupled to the patient support for moving the patient support between the lowered position and the raised position. The patient support comprises a backrest and a seat. Movement of the patient support independent or separately from the base and without interfering with the storage areas within the base may allow for the efficient use of the examination table as a storage area. | 10-01-2009 |
20110047704 | MEDICAL EXAMINATION TABLE - A medical examination table is provided. The medical examination table comprises a base providing a storage area, a patient support movable independent of the base between a lowered position and a raised position, and a lift mechanism coupled to the patient support for moving the patient support between the lowered position and the raised position. The patient support comprises a backrest and a seat. Movement of the patient support independent or separately from the base and without interfering with the storage areas within the base may allow for the efficient use of the examination table as a storage area. | 03-03-2011 |
20120186018 | MEDICAL EXAMINATION TABLE - A medical examination table is provided. The medical examination table comprises a base providing a storage area, a patient support movable independent of the base between a lowered position and a raised position, and a lift mechanism coupled to the patient support for moving the patient support between the lowered position and the raised position. The patient support comprises a backrest and a seat. Movement of the patient support independent or separately from the base and without interfering with the storage areas within the base may allow for the efficient use of the examination table as a storage area. | 07-26-2012 |
20120255123 | MEDICAL EXAMINATION TABLE - A medical examination table includes a seat, a compartment below the seat, a first extension, a second extension, a lift mechanism, a base, and a storage section formed in the base. The first extension is configured to be stored in the compartment, and is further configured to project outward relative to the seat when in an extended configuration of the first extension. The second extension is configured to be stored in the compartment with the first extension, and is further configured to project outward relative to the first extension when in an extended configuration of the second extension. The lift mechanism is configured to raise and lower the seat, the compartment, and the first and second extensions. The base is coupled to the lift mechanism. | 10-11-2012 |
20150224007 | MEDICAL EXAMINATION TABLE - A medical examination table includes a seat, a compartment below the seat, a first extension, a second extension, a lift mechanism, a base, and a storage section formed in the base. The first extension is configured to be stored in the compartment, and is further configured to project outward relative to the seat when in an extended configuration of the first extension. The second extension is configured to be stored in the compartment with the first extension, and is further configured to project outward relative to the first extension when in an extended configuration of the second extension. The lift mechanism is configured to raise and lower the seat, the compartment, and the first and second extensions. The base is coupled to the lift mechanism. The storage section, formed in the base, is disposed behind the seat, where an internal dimension of the compartment is limited by the positioning of the storage section. Configuring the first and second extensions in the extended configurations elongates the medical examination table by a distance greater than the internal dimension of the compartment. | 08-13-2015 |
Patent application number | Description | Published |
20090013691 | PHASE CHANGE MATERIAL THERMAL POWER GENERATOR - An energy producing device, for example a submersible vehicle for descending or ascending to different depths within water or ocean, is disclosed. The vehicle comprises a temperature-responsive material to which a hydraulic fluid is associated. A pressurized storage compartment stores the fluid as soon as the temperature-responsive material changes density. The storage compartment is connected with a hydraulic motor, and a valve allows fluid passage from the storage compartment to the hydraulic motor. An energy storage component, e.g. a battery, is connected with the hydraulic motor and is charged by the hydraulic motor when the hydraulic fluid passes through the hydraulic motor. Upon passage in the hydraulic motor, the fluid is stored in a further storage compartment and is then sent back to the area of the temperature-responsive material. | 01-15-2009 |
20090127859 | POWER GENERATION SYSTEMS AND METHODS - A power generation system includes a plurality of submerged mechanical devices. Each device includes a pump that can be powered, in operation, by mechanical energy to output a pressurized output liquid flow in a conduit. Main output conduits are connected with the device conduits to combine pressurized output flows output from the submerged mechanical devices into a lower number of pressurized flows. These flows are delivered to a location remote of the submerged mechanical devices for power generation. | 05-21-2009 |
20110314811 | PHASE CHANGE MATERIAL THERMAL POWER GENERATOR - An energy producing device, for example a submersible vehicle for descending or ascending to different depths within water or ocean, is disclosed. The vehicle comprises a temperature-responsive material to which a hydraulic fluid is associated. A pressurized storage compartment stores the fluid as soon as the temperature-responsive material changes density. The storage compartment is connected with a hydraulic motor, and a valve allows fluid passage from the storage compartment to the hydraulic motor. An energy storage component, e.g. a battery, is connected with the hydraulic motor and is charged by the hydraulic motor when the hydraulic fluid passes through the hydraulic motor. Upon passage in the hydraulic motor, the fluid is stored in a further storage compartment and is then sent back to the area of the temperature-responsive material. | 12-29-2011 |
20120091942 | SUBMERGED CHARGING STATION - A submerged charging station having a rechargeable energy producing device is disclosed. The device comprises a submerged thermally based electric generator that comprises a temperature-responsive material that utilizes differences in depths in order to generate energy. The submerged thermally based electric generator changes depths along a tether that is attached to a buoy and an anchor. The submerged thermally based electric generator provides energy to a battery, which can be part of the charging station, or to an autonomous underwater vehicle (AUV) that travels to different charging stations to be recharged. | 04-19-2012 |
20130028729 | POWER GENERATION SYSTEMS AND METHODS - A power generation system with a plurality of mechanical devices is described. Each mechanical device has energy-capturing blades and a hydraulic pump. A power generation arrangement remote of the mechanical devices is also disclosed. Each mechanical device can include a device output conduit configured to output a pressurized output flow and a device input conduit for receiving a low pressure flow. The power generation arrangement can comprise a plurality of hydraulic generators, such that each mechanical device can be connected to the plurality of hydraulic generators. A method for power generating is further disclosed, where a pressurized output flow can be delivered in parallel from the mechanical devices to the plurality of hydraulic generators. Some of the hydraulic generators can be switched off when the power transmitted from the blades is low. | 01-31-2013 |
Patent application number | Description | Published |
20100138384 | Policy-based management of a redundant array of independent nodes - An archive cluster application runs in a distributed manner across a redundant array of independent nodes. Each node preferably runs a complete archive cluster application instance. A given nodes provides a data repository, which stores up to a large amount (e.g., a terabyte) of data, while also acting as a portal that enables access to archive files. Each symmetric node has a set of software processes, e.g., a request manager, a storage manager, a metadata manager, and a policy manager. The request manager manages requests to the node for data (i.e., file data), the storage manager manages data read/write functions from a disk associated with the node, and the metadata manager facilitates metadata transactions and recovery across the distributed database. The policy manager implements one or more policies, which are operations that determine the behavior of an “archive object” within the cluster. The archive cluster application provides object-based storage. Preferably, the application permanently associates metadata and policies with the raw archived data, which together comprise an archive object. Object policies govern the object's behavior in the archive. As a result, the archive manages itself independently of client applications, acting automatically to ensure that all object policies are valid. | 06-03-2010 |
20110106770 | Fixed content storage within a partitioned content platform using namespaces, with versioning - Archive cluster management is enhanced by logically partitioning a physical cluster that comprises a redundant array of independent nodes. Using a web-based interface, an administrator defines one or more “tenants” within the archive cluster, wherein a tenant has a set of attributes: namespaces, administrative accounts, data access accounts, and a permission mask. A namespace is a logical partition of the cluster that serves as a collection of objects typically associated with at least one defined application. Each namespace has a private file system with respect to other namespaces. This approach enables a user to segregate cluster data into logical partitions. Using the administrative interface, a namespace associated with a given tenant is selectively configured without affecting a configuration of at least one other namespace in the set of namespaces. One configuration option is “versioning,” by which an administrator can elect to enable multiple versions of a same data object to be stored in association with a given namespace. Each version of the data object has associated therewith a time of storage attribute that uniquely identifies the version in the archive. Once versioning is enabled for a namespace, the administrator can set a configuration parameter identifying a time period for maintaining a version in the archive cluster, as well as a parameter for a time period for maintaining a version of the data object on a replica associated with the archive cluster. A current version of the data object is freely accessible in the archive, and a prior version may be browsed via an API. Preferably, versioning is disabled for a data object under retention. | 05-05-2011 |
20110106802 | Fixed content storage within a partitioned content platform using namespaces - Content platform management is enhanced by logically partitioning a physical cluster that comprises a redundant array of independent nodes. Using an interface, an administrator defines one or more “tenants” within the archive cluster, wherein a tenant has a set of attributes including, for example, namespaces, administrative accounts, data access accounts, and a permission mask. A namespace is a logical partition of the cluster that serves as a collection of objects typically associated with at least one defined application. Each namespace has a private file system such that access to one namespace (and its associated objects) does not enable a user to access objects in another namespace. A namespace has capabilities (e.g., read, write, delete, purge, and the like) that a namespace administrator can choose to enable or disable for a given data account. Using the interface, an administrator for the tenant creates and manages namespaces such that the cluster then is logically partitioned into a set of namespaces, wherein one or more namespaces are associated with a given tenant. This approach enables a user to segregate cluster data into logical partitions. Using the administrative interface, a namespace associated with a given tenant is selectively configured without affecting a configuration of at least one other namespace in the set of namespaces. This architecture enables support for many top level tenants, with multiple namespaces per tenant, and wherein configuration is effected at the level of a namespace. | 05-05-2011 |
20110191300 | Metadata management for fixed content distributed data storage - An archival storage cluster of preferably symmetric nodes includes a metadata management system that organizes and provides access to given metadata, preferably in the form of metadata objects. Each metadata object may have a unique name, and metadata objects are organized into regions. Preferably, a region is selected by hashing one or more object attributes (e.g., the object's name) and extracting a given number of bits of the resulting hash value. The number of bits may be controlled by a configuration parameter. Each region is stored redundantly. A region comprises a set of region copies. In particular, there is one authoritative copy of the region, and zero or more backup copies. The number of backup copies may be controlled by a configuration parameter. Region copies are distributed across the nodes of the cluster so as to balance the number of authoritative region copies per node, as well as the number of total region copies per node. Backup region copies are maintained synchronized to their associated authoritative region copy. | 08-04-2011 |
20120246126 | Policy-based management of a redundant array of independent nodes - An archive cluster application runs across a redundant array of independent nodes. Each node runs an archive cluster application instance comprising a set of software processes: a request manager, a storage manager, a metadata manager, and a policy manager. The request manager manages requests for data, the storage manager manages data read/write functions, and the metadata manager facilitates metadata transactions and recovery. The policy manager implements policies, which are operations that determine the behavior of an “archive object” within the cluster. The archive cluster application provides object-based storage. It associates metadata and policies with the raw archived data, which together comprise an archive object. Object policies govern the object's behavior in the archive. The archive manages itself independently of client applications, acting automatically to ensure that object policies are valid. | 09-27-2012 |
20130036088 | Metadata management for fixed content distributed data storage - An archival storage cluster of symmetric nodes includes a metadata management system that organizes metadata objects. Each metadata object may have a unique name, and metadata objects are organized into regions. A region is selected by hashing one or more object attributes and extracting a given number of bits of the resulting hash value. The number of bits may be controlled by a configuration parameter. Each region is stored redundantly. A region comprises a set of region copies. In particular, there is one authoritative copy of the region, and zero or more backup copies. The number of backup copies may be controlled by a configuration parameter. Region copies are distributed across the nodes of the cluster to balance the number of authoritative region copies per node, and the number of total region copies per node. Backup region copies are maintained synchronized to their associated authoritative region copy. | 02-07-2013 |
20140181055 | Policy-based management of a redundant array of independent nodes - An archive cluster application runs across a redundant array of independent nodes. Each node runs an archive cluster application instance comprising a set of software processes: a request manager, a storage manager, a metadata manager, and a policy manager. The request manager manages requests for data, the storage manager manages data read/write functions, and the metadata manager facilitates metadata transactions and recovery. The policy manager implements policies, which are operations that determine the behavior of an “archive object” within the cluster. The archive cluster application provides object-based storage. It associates metadata and policies with the raw archived data, which together comprise an archive object. Object policies govern the object's behavior in the archive. The archive manages itself independently of client applications, acting automatically to ensure that object policies are valid. | 06-26-2014 |
20140289277 | FIXED CONTENT STORAGE WITHIN A PARTITIONED CONTENT PLATFORM USING NAMESPACES - Content platform management is enhanced by logically partitioning a physical cluster that comprises a redundant array of independent nodes. Using an interface, an administrator defines one or more “tenants” within the archive cluster, wherein a tenant has a set of attributes including, for example, namespaces, administrative accounts, data access accounts, and a permission mask. A namespace is a logical partition of the cluster that serves as a collection of objects typically associated with at least one defined application. Each namespace has a private file system such that access to one namespace (and its associated objects) does not enable a user to access objects in another namespace. A namespace has capabilities (e.g., read, write, delete, purge, and the like) that a namespace administrator can choose to enable or disable for a given data account. | 09-25-2014 |
Patent application number | Description | Published |
20090233285 | SPECIFIC METHOD OF PROSTATE CANCER DETECTION BASED ON PCA3 GENE, AND KITS THEREFOR - The present invention relates, in general, to prostate cancer. More specifically, the present invention relates to a method to diagnose prostate cancer in a patient by detecting a PCA3 sequence, and more particularly a PCA3 RNA, the PCA3 sequence detected in a sample from the patient being specifically associated with prostate cancer. In a particular embodiment the method and kit enables an amplification of a PCA3 RNA through an exon-exon junction of a spliced PCA3 mRNA. The invention also relates to methods and kits to detect such an amplified PCA3 RNA, using a probe which spans the amplified exon-exon junction. In particular the methods and kits are designed to detect a PCA3 RNA which lacks one intron or more, and in particular case is intron-less. The invention further relates to a method of detecting PCA3 RNA expressed in non-prostate tissue or cells of the urinary tract, that comprises PCA3 intron 3. | 09-17-2009 |
20110165178 | DIAGNOSIS OF PROSTATE CANCER - The present invention relates to vitro diagnosis methods of prostate cancer from a test biological sample, comprising measuring the expression level of KIAA0153 in said test biological sample, as well as to methods for screening compounds inhibiting KIAA0153 gene expression or biological activity and uses of such KIAA0153 inhibiting compounds. | 07-07-2011 |
20120108453 | MOLECULAR MARKERS IN PROSTATE CANCER - The present invention relates to methods for diagnosing prostate cancer and especially diagnosing LG, i.e., individuals with good prognosis; HG, i.e., individuals with poor prognosis of primary tumour; PrCa Met, i.e., individuals with poor prognosis and metastasis; and CRPC, i.e., individuals with poor prognosis suffering from aggressive localized disease. Specifically, the present invention relates to method for establishing the presence, or absence, of prostate cancer in a human individual comprising: a) determining the expression of one or more genes chosen from the group consisting of RRM2, HOXC6, TGM4, RORB, HOXDlO, SFRP2, and SNAI2 in a sample originating from said human individual; b) establishing up, or down, regulation of expression of said one or more genes as compared to expression of said respective one or more genes in a sample originating from said human individual not comprising prostate tumour cells or prostate tumour tissue, or from an individual not suffering from prostate cancer; and c) establishing the presence, or absence, of prostate cancer based on the established up- or down regulation of said one or more genes. | 05-03-2012 |
20120142553 | Molecular Markers in Kidney Cancer - The present invention relates to methods for establishing the presence, or absence, of a kidney, or renal, tumour in a human individual suspected of suffering from kidney, or renal, cancer. Specifically, the present invention relates to methods for establishing the presence, or absence, of a kidney tumour in a human individual suspected of suffering from kidney cancer comprising: a) determining the expression of one or more genes chosen from the group consisting of NDUFA4l2, ANGPTL4, EGLN3, PTHLH, and ATP6V1B1 in a sample originating from said human individual; b) establishing up, or down, regulation of expression of said one or more genes as compared to expression of said respective one or more genes in a sample originating from said human individual not comprising kidney tumour cells or tissue, or from an individual, or group of individuals, not suffering from kidney cancer; and c) establishing the presence, or absence, of a kidney tumour based on the established up- or down regulation of said one or more genes. | 06-07-2012 |
20120309006 | SPECIFIC METHOD OF PROSTATE CANCER DETECTION BASED ON PCA3 GENE, AND KITS THEREFOR - The invention relates to a method to diagnose prostate cancer by detecting a PCA3 sequence. In one embodiment the method and kit enables amplification of PCA3 RNA through an exon-exon junction of a spliced PCA3 mRNA, and methods and kits to detect an amplified PCA3 RNA, using a probe which spans the amplified exon-exon junction. The methods and kits can detect a PCA3 RNA lacking one intron or more. Also provided are methods of detecting PCA3 RNA expressed in non-prostate tissue or cells of the urinary tract, which comprises PCA3 intron 3. In addition, methods are provided to determine whether a sample from a subject contains or lacks prostate cells, by performing a hybridization and/or amplification reaction on RNA from the sample to detect the presence or level of PCA3 RNA that lacks at least one intron and distinguishing a prostate cell from a non-prostate cell. | 12-06-2012 |
20120309007 | PROSTATE CANCER PROGNOSTIC COMPOSITIONS AND KITS - Described herein are method, compositions and kits for prognosis of prostate cancer. The methods comprise: determining the ratio of PCA3 and of a prostate-specific marker expression in a urine sample and correlating the value of the PCA3/prostate-specific marker ratio with the aggressiveness and mortality risk of prostate cancer in the subject. The present invention features a method for prognosing prostate cancer in a sample of a patient comprising: assessing the amount of a prostate cancer specific PCA3 mRNA and the amount of prostate-specific marker in the sample; determining a ratio value of this amount of prostate cancer specific PCA3 mRNA over the amount of prostate-specific marker; comparing the ratio value to at least one predetermined cut-off value, wherein a ratio value above the predetermined cut-off value is indicative of a higher risk of mortality of prostate cancer as compared to a ratio value below the predetermined cut-off value. | 12-06-2012 |
20130261171 | PROSTATE CANCER PROGNOSTIC COMPOSITIONS AND KITS - Described herein are method, compositions and kits for prognosis of prostate cancer. The methods include determining the ratio of PCA3 and of a prostate-specific marker expression in a urine sample and correlating the value of the PCA3/prostate-specific marker ratio with the aggressiveness and mortality risk of prostate cancer in the subject. The method for prognosing prostate cancer in a sample of a patient includes assessing the amount of a prostate cancer specific PCA3 mRNA and the amount of prostate-specific marker in the sample; determining a ratio value of this amount of prostate cancer specific PCA3 mRNA over the amount of prostate-specific marker; comparing the ratio value to at least one predetermined cut-off value, wherein a ratio value above the predetermined cut-off value is indicative of a higher risk of mortality of prostate cancer as compared to a ratio value below the predetermined cut-off value. | 10-03-2013 |
20150017640 | Combinations of Molecular Markers in Prostate Cancer providing a Diagnostic Tool with Improved Sensitivity/Specificity - The present invention relates to methods for in vitro establishing, or diagnosing, high grade or low grade prostate cancer in a sample, preferably from a readily obtainable sample such as an urine, a prostatic fluid or ejaculate sample or a processed, or derived sample thereof, originating from human individual suspected of suffering from prostate cancer using expression level analysis of a combination of two, or three molecular markers for prostate cancer selected from DLX1, HOXC6 and HOXD10. The present invention further relates to the use in expression level analysis of these combined markers for in vitro establishing high grade or low grade prostate cancer and to a kit of parts providing expression analysis of combinations of the present molecular markers for establishing high grade or low grade prostate cancer. | 01-15-2015 |
20150307948 | PROSTATE CANCER PROGNOSTIC COMPOSITIONS AND KITS - Described herein are method, compositions and kits for prognosis of prostate cancer. The methods include determining the ratio of PCA3 and of a prostate-specific marker expression in a urine sample and correlating the value of the PCA3/prostate-specific marker ratio with the aggressiveness and mortality risk of prostate cancer in the subject. The method for prognosing prostate cancer in a sample of a patient includes assessing the amount of a prostate cancer specific PCA3 mRNA and the amount of prostate-specific marker in the sample; determining a ratio value of this amount of prostate cancer specific PCA3 mRNA over the amount of prostate-specific marker; comparing the ratio value to at least one predetermined cut-off value, wherein a ratio value above the predetermined cut-off value is indicative of a higher risk of mortality of prostate cancer as compared to a ratio value below the predetermined cut-off value. | 10-29-2015 |
Patent application number | Description | Published |
20090031855 | POROUS BODIES AND METHODS - Systems and methods for treating a fluid with a body are disclosed. Various aspects involve treating a fluid with a porous body. In select embodiments, a body comprises ash particles, and the ash particles used to form the body may be selected based on their providing one or more desired properties for a given treatment. Various bodies provide for the reaction and/or removal of a substance in a fluid, often using a porous body comprised of ash particles. Computer-operable methods for matching a source material to an application are disclosed. Certain aspects feature a porous body comprised of ash particles, the ash particles have a particle size distribution and interparticle connectivity that creates a plurality of pores having a pore size distribution and pore connectivity, and the pore size distribution and pore connectivity are such that a first fluid may substantially penetrate the pores. | 02-05-2009 |
20100133106 | Porous Bodies and Methods - Systems and methods for treating a fluid with a body are disclosed. Various aspects involve treating a fluid with a porous body. In select embodiments, a body comprises ash particles, and the ash particles used to form the body may be selected based on their providing one or more desired properties for a given treatment. Various bodies provide for the reaction and/or removal of a substance in a fluid, often using a porous body comprised of ash particles. Computer-operable methods for matching a source material to an application are disclosed. Certain aspects feature a porous body comprised of ash particles, the ash particles have a particle size distribution and interparticle connectivity that creates a plurality of pores having a pore size distribution and pore connectivity, and the pore size distribution and pore connectivity are such that a first fluid may substantially penetrate the pores. | 06-03-2010 |
20100298124 | Porous Bodies and Methods - Systems and methods for treating a fluid with a body are disclosed. Various aspects involve treating a fluid with a porous body. In select embodiments, a body comprises ash particles, and the ash particles used to form the body may be selected based on their providing one or more desired properties for a given treatment. Various bodies provide for the reaction and/or removal of a substance in a fluid, often using a porous body comprised of ash particles. Computer-operable methods for matching a source material to an application are disclosed. Certain aspects feature a porous body comprised of ash particles, the ash particles have a particle size distribution and interparticle connectivity that creates a plurality of pores having a pore size distribution and pore connectivity, and the pore size distribution and pore connectivity are such that a first fluid may substantially penetrate the pores. | 11-25-2010 |
20110229389 | Porous Bodies and Methods - Systems and methods for treating a fluid with a body are disclosed. Various aspects involve treating a fluid with a porous body. In select embodiments, a body comprises ash particles, and the ash particles used to form the body may be selected based on their providing one or more desired properties for a given treatment. Various bodies provide for the reaction and/or removal of a substance in a fluid, often using a porous body comprised of ash particles. Computer-operable methods for matching a source material to an application are disclosed. Certain aspects feature a porous body comprised of ash particles, the ash particles have a particle size distribution and interparticle connectivity that creates a plurality of pores having a pore size distribution and pore connectivity, and the pore size distribution and pore connectivity are such that a first fluid may substantially penetrate the pores. | 09-22-2011 |
20110229390 | Porous Bodies and Methods - Systems and methods for treating a fluid with a body are disclosed. Various aspects involve treating a fluid with a porous body. In select embodiments, a body comprises ash particles, and the ash particles used to form the body may be selected based on their providing one or more desired properties for a given treatment. Various bodies provide for the reaction and/or removal of a substance in a fluid, often using a porous body comprised of ash particles. Computer-operable methods for matching a source material to an application are disclosed. Certain aspects feature a porous body comprised of ash particles, the ash particles have a particle size distribution and interparticle connectivity that creates a plurality of pores having a pore size distribution and pore connectivity, and the pore size distribution and pore connectivity are such that a first fluid may substantially penetrate the pores. | 09-22-2011 |
20120079941 | Porous Bodies and Methods - Systems and methods for treating a fluid with a body are disclosed. Various aspects involve treating a fluid with a porous body. In select embodiments, a body comprises ash particles, and the ash particles used to form the body may be selected based on their providing one or more desired properties for a given treatment. Various bodies provide for the reaction and/or removal of a substance in a fluid, often using a porous body comprised of ash particles. Computer-operable methods for matching a source material to an application are disclosed. Certain aspects feature a porous body comprised of ash particles, the ash particles have a particle size distribution and interparticle connectivity that creates a plurality of pores having a pore size distribution and pore connectivity, and the pore size distribution and pore connectivity are such that a first fluid may substantially penetrate the pores. | 04-05-2012 |
20120082603 | Porous Bodies and Methods - Systems and methods for treating a fluid with a body are disclosed. Various aspects involve treating a fluid with a porous body. In select embodiments, a body comprises ash particles, and the ash particles used to form the body may be selected based on their providing one or more desired properties for a given treatment. Various bodies provide for the reaction and/or removal of a substance in a fluid, often using a porous body comprised of ash particles. Computer-operable methods for matching a source material to an application are disclosed. Certain aspects feature a porous body comprised of ash particles, the ash particles have a particle size distribution and interparticle connectivity that creates a plurality of pores having a pore size distribution and pore connectivity, and the pore size distribution and pore connectivity are such that a first fluid may substantially penetrate the pores. | 04-05-2012 |
20120171587 | Conducting ceramics for electrochemical systems - The present invention generally relates to conducting materials such as mixed ionically and electrically conducting materials. A variety of materials, material compositions, materials with advantageous ratios of ionically and electrically conducting components, structures including such materials, and the like are provided in accordance with the invention. In one aspect, the invention relates to conducting ceramics for electrochemical systems and, in particular, to mixed ionically and electrically conducting ceramics which can be used, for example, for electrochemical systems and, in particular, to mixed ionically and electrically conducting ceramics which can be used, for example, for hydrogen gas generation from a gasified hydrocarbon stream. One aspect of the invention provides a material comprising a first phase comprising a ceramic ionic conductor, and a second phase comprising a ceramic electrical conductor. An example of such a material is a material comprising ZrO | 07-05-2012 |
20120251414 | Porous Bodies and Methods - Systems and methods for treating a fluid with a body are disclosed. Various aspects involve treating a fluid with a porous body. In select embodiments, a body comprises ash particles, and the ash particles used to form the body may be selected based on their providing one or more desired properties for a given treatment. Various bodies provide for the reaction and/or removal of a substance in a fluid, often using a porous body comprised of ash particles. Computer-operable methods for matching a source material to an application are disclosed. Certain aspects feature a porous body comprised of ash particles, the ash particles have a particle size distribution and interparticle connectivity that creates a plurality of pores having a pore size distribution and pore connectivity, and the pore size distribution and pore connectivity are such that a first fluid may substantially penetrate the pores. | 10-04-2012 |
20140004021 | Porous Bodies and Methods | 01-02-2014 |
20140364302 | Porous Bodies and Methods - Systems and methods for treating a fluid with a body are disclosed. Various aspects involve treating a fluid with a porous body. In select embodiments, a body comprises ash particles, and the ash particles used to form the body may be selected based on their providing one or more desired properties for a given treatment. Various bodies provide for the reaction and/or removal of a substance in a fluid, often using a porous body comprised of ash particles. Computer-operable methods for matching a source material to an application are disclosed. Certain aspects feature a porous body comprised of ash particles, the ash particles have a particle size distribution and interparticle connectivity that creates a plurality of pores having a pore size distribution and pore connectivity, and the pore size distribution and pore connectivity are such that a first fluid may substantially penetrate the pores. | 12-11-2014 |
Patent application number | Description | Published |
20090256067 | Electron capture dissociation in radiofrequency ion traps - A system and method that includes injecting low-energy electrons in a radiofrequency (RF) ion trap in order to dissociate positive ions by electron capture. The system includes an ion trap, a controller to provide RF that can be switched on and off rapidly, and a source of low-energy electrons that can be turned on and off synchronously with the radiofrequency on/off periods. | 10-15-2009 |
20110154918 | SURFACE SAMPLING MOBILE CHEMICAL DETECTION PROBE - A sampling device that contains a heated porous inlet and a transfer line. The device provides sample compounds present as vapor, liquid, or solid, in air, or on surfaces such as soil. The sample device can collect and deliver the sample to an analyzer in real time and can operate while in motion such as on a moving vehicle. The sampling device is especially useful to screen toxic and hazardous compounds that might be contaminating an inhabited area. | 06-30-2011 |
20110181288 | Trace explosives personnel screening system - A detector system with a portal including a plurality of output ports that direct a plurality of output airstreams in an essentially horizontal direction, and a plurality of intake ports that pull in air. The system also includes at least one concentrator coupled to at least one of the intake ports, and a detector coupled to the concentrator. The horizontally oriented output airstreams and multiple intake ports provide a system that can rapidly screen multiple people for explosives and other substances. | 07-28-2011 |
20110278447 | PHOTOEMISSION INDUCED ELECTRON IONIZATION - A monitor that can detect at least one molecule. The monitor includes a housing with a passage that can receive a sample, and a photocathode that is located within the housing. The monitor also includes a first ultraviolet light source that can direct ultraviolet light onto the photocathode to create electrons that ionize molecules within the sample, and a detector that is coupled to the housing to detect at least one ionized molecule. The monitor enables electron ionization (EI) of a sample for chemical analysis without the disadvantages of current methods that use a hot filament or other thermal cathode devices. | 11-17-2011 |
20130091963 | HAND-HELD TRACE VAPOR/PARTICLE SAMPLING SYSTEM - A sampling system that contains filter components for collecting and concentrating vapor and particles in high-volume flows. The sample is then vaporized and delivered to a detector at a low-volume flow. The invention also has a sampling probe that contains an air-jet to help dislodge particles from surfaces and a heating lamp to help vaporize compounds on surfaces or objects. The sampling system is especially useful for screening for explosives and other illicit chemicals and toxins on people, baggage, cargo, and other objects. | 04-18-2013 |
20150268147 | HAND-HELD TRACE PARTICLE SAMPLING SYSTEM AND METHOD OF OPERATING THE SAME - A particle impact device for a hand-held trace particle detection system includes an intake manifold that includes a first conduit defining an intake port. The intake port defines a first transport area. The intake manifold also includes a second conduit coupled to the first conduit. The second conduit defines a discharge port that defines a second transport area. The first transport area is greater than the second transport area. The particle impact device also includes a combined deposition and deflection apparatus positioned downstream of the discharge port. The combined deposition and deflection apparatus defines a deposition and deflection surface positioned a predetermined distance from the discharge port. The deposition and deflection surface is configured to deflect a fluid stream and collect at least a portion of particles entrained in the fluid stream. | 09-24-2015 |
Patent application number | Description | Published |
20080232663 | SYSTEM AND METHOD FOR REMOTE NAVIGATION OF A SPECIMEN - A method of providing remote navigation of a specimen includes receiving a command to remotely control a microscope and a camera coupled with the microscope to view a portion of a specimen disposed on the microscope, capturing a digital image of the portion with the camera in response to the command, representing the digital image as a plurality of digital image components, each of the digital image components providing a different level of detail of the image, and transmitting the components in sequential order of increasing level of detail from least detailed to most detailed. | 09-25-2008 |
20090074284 | SYSTEM AND METHOD FOR CREATING MAGNIFIED IMAGES OF A MICROSCOPE SLIDE - A method and system for creating a digital, virtual slide having optimum image quality characteristics. Multiple regions of a physical slide are identified as well as at least two focus z-positions z | 03-19-2009 |
20100034437 | System and method for reconstructing a diagnostic trajectory - A system and method for reconstructing a diagnostic trajectory. | 02-11-2010 |
20100067759 | System and Method for Remote Navigation of a Specimen - A method of providing remote navigation of a specimen includes receiving a command to remotely control a microscope and a camera coupled with the microscope to view a portion of a specimen disposed on the microscope, capturing a digital image of the portion with the camera in response to the command, representing the digital image as a plurality of digital image components, each of the digital image components providing a different level of detail of the image, and transmitting the components in sequential order of increasing level of detail from least detailed to most detailed. | 03-18-2010 |
20100073472 | Intergrated virtual slide and live microscope system - A method for creating a virtual slide is provided. A virtual slide is a digital representation of an area of interest of a microscopic slide. One method is to use a motorized microscope that can move a specimen with respect to a microscopic objective. With such a system, one can capture one or more images through a microscopic objective, such that a region of interest is imaged. Each image is then joined together to form a composite or “virtual image.” In one embodiment, after a virtual slide is created, a user may fully utilize the full capabilities of the remote microscope. Among these capabilities is a set of “optical objectives” and “virtual objectives.” Optical objectives are images created by digitizing an image through a microscopic objective in real time. Virtual objectives are digitally created magnifications created by utilizing the existing virtual slide data to digitally create a field of view. | 03-25-2010 |